Scholarlink

Background <p>Alternative splicing (AS) plays a critical role in gene regulation, contributing to transcriptomic complexity and disease progression.</p> Methods <p>In this study, we investigated the regulatory effects of AS in alcoholic hepatitis (AH) using transcriptomic data from 41 samples (Normal: 21; AH: 20) from three projects (PRJNA597328, PRJNA600011 and PRJNA656197) from the NCBI database.</p> Results <p>A total of 1,061,774 transcripts were identified, of which 42.23% were novel and not annotated in the reference genome, highlighting the diversity of transcriptomic variation in AH. Furthermore, we identified 1,655 aberrant alternative splicing events (AASEs) associated with 1,170 genes, 487 of which were significantly correlated with 22 differentially expressed RNA-binding proteins (RBPs). Additionally, 4,745 splicing quantitative trait loci (sQTLs) were identified in AH, mapped to 2,438 genes enriched in the regulation of some metabolic processes. Notably, several susceptibility sQTL locis were located within known alcoholic liver disease (ALD) associated genes, including <i>GAB1</i>, <i>TJP2</i> and <i>RCAN1</i>. These findings suggest that AS, through its regulation by RBPs and genetic variants (sQTLs), significantly influences key biological processes in AH, including fatty acid degradation and ferroptosis, processes that are central to the clinical manifestations of AH.</p> Conclusions <p>This study provides new insights into the molecular mechanisms underlying AH, emphasizing the importance of AS and its regulatory factors in disease progression.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Aberrant alternative splicing in alcoholic hepatitis: regulatory roles of RBPs and sQTLs

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月14日

查看全文
  • Jinjiang Zhao,
  • Jie Cheng,
  • Shaohua Liang,
  • Wei Guo,
  • Beibei Zhao,
  • Huipeng Zhang,
  • Xianghuang Mei,
  • Ning Zhang,
  • Meifang Sheng

摘要

Background

Alternative splicing (AS) plays a critical role in gene regulation, contributing to transcriptomic complexity and disease progression.

Methods

In this study, we investigated the regulatory effects of AS in alcoholic hepatitis (AH) using transcriptomic data from 41 samples (Normal: 21; AH: 20) from three projects (PRJNA597328, PRJNA600011 and PRJNA656197) from the NCBI database.

Results

A total of 1,061,774 transcripts were identified, of which 42.23% were novel and not annotated in the reference genome, highlighting the diversity of transcriptomic variation in AH. Furthermore, we identified 1,655 aberrant alternative splicing events (AASEs) associated with 1,170 genes, 487 of which were significantly correlated with 22 differentially expressed RNA-binding proteins (RBPs). Additionally, 4,745 splicing quantitative trait loci (sQTLs) were identified in AH, mapped to 2,438 genes enriched in the regulation of some metabolic processes. Notably, several susceptibility sQTL locis were located within known alcoholic liver disease (ALD) associated genes, including GAB1, TJP2 and RCAN1. These findings suggest that AS, through its regulation by RBPs and genetic variants (sQTLs), significantly influences key biological processes in AH, including fatty acid degradation and ferroptosis, processes that are central to the clinical manifestations of AH.

Conclusions

This study provides new insights into the molecular mechanisms underlying AH, emphasizing the importance of AS and its regulatory factors in disease progression.